| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.2 | 0.0002 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.099 | 0.002 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.16 | 0.003 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.099 | 0.004 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.095 | 0.004 |